Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

Kidney International

Volumn 55, Issue 6, 1999, Pages 2423-2432

  Hirschberg, Raimund ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Kopple, Joel ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Lipsett, Pamela ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Benjamin, Ernest ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Minei, Joseph ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Albertson, Timothy ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Munger, Mark ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Metzler, Michael ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Zaloga, Gary ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Murray, Michael ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Lowry, Stephen ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Conger, John ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   McKeown, Wade ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   O'Shea, Michael ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Baughman, Robert ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Wood, Kenneth ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Haupt, Marilyn ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Kaiser, Roger ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Simms, Hank ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Warnock, David ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Summer, Warren ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Hintz, Raymond ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Myers, Brian ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Haenftling, Kathrine ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Capra, William ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Pike, Marilyn ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Guler, Hans Peter ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   more..

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g UNIVERSITY OF MISSOURI   (United States)

^h WAKE FOREST UNIVERSITY   (United States)

ⁱ MAYO CLINIC   (United States)

^j Department of Obstetrics Gynecology   (United States)

^k UNIVERSITY OF COLORADO   (United States)

^l UNIVERSITY OF KENTUCKY   (United States)

^m Baystate Med Cent   (United States)

ⁿ UNIVERSITY OF WISCONSIN MADISON   (United States)

^o DETROIT RECEIVING HOSPITAL   (United States)

^p ERIE COUNTY MEDICAL CENTER   (United States)

^q RHODE ISLAND HOSPITAL   (United States)

^r UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^s LOUISIANA STATE UNIVERSITY   (United States)

^t STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^u NOVARTIS PHARMA AG   (Switzerland)

more..

Author keywords

Comorbidity in ARF; Hemodynamics; Ischemia; Nephrotoxicity; Protein catabolism

Indexed keywords

ALBUMIN; CREATININE; PLACEBO; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; TRANSFERRIN; UREA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY CLEARANCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION; TEACHING HOSPITAL; ULTRAFILTRATION; UREA BLOOD LEVEL; URINE VOLUME;

EID: 0032991586     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00463.x     Document Type: Article

References (38)

1. 1. Maher ER, Robinson KN, Scoble JE, Farrimond JG, Browne DR, Sweny P, Moorhead JF: Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 72:857-866, 1989
2. 2. Bellomo R, Farmer M, Parkin G, Wright C, Boyce N: Severe acute renal failure: A comparison of acute continuous hemodiafiltration and conventional dialytic therapy. Nephron 71:59-64, 1995
3. 3. Keane WF, Hirata-Dulas CA, Bullock ML, Ney AL, Guay DR, Kalil RS, Dinarello CA, Halstenson CE, Peterson PK: Adjunclive therapy with intravenous human immunoglobulin G improves survival of patients with acute renal failure. J Am Soc Nephrol 2:841-847, 1991
4. 4. Douma CE, Redekop WK, Van Der Meulen JH, Van Olden RW, Haeck J, Struijk DG, Krediet RT: Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol 8:111-117, 1997
5. 5. Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER: Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 121:101-106, 1989
6. 6. Guler HP, Schmid C, Zapf J, Froesch ER: Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 86:2868-2872, 1989
7. 7. Hirschberg R, Kopple JD: Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 83:326-330, 1989
8. 8. Hirschberg R, Kopple JD, Blantz RC, Tucker BJ: Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 87:1200-1206, 1991
9. 9. Hirschberg R, Brunori G, Kopple JD, Guler HP: Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43:387-397, 1993
10. 10. Miller SB, Martin DR, Kissane J, Hammerman MR: Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880, 1992
11. 11. O'Shea M, Miller SB, Hammerman MR: Effects of IGF-I on renal function in patients with chronic renal failure. Am J Physiol 264:F917-F922, 1993
12. 12. Clark R, Mortensen D, Rabkin R: Recovery from acute ischaemic renal failure is accelerated by des-(1-3)-insulin-like growth factor-1. Clin Sci (Colch) 86:709-714, 1994
13. 13. Ding H, Kopple JD, Cohen A, Hirschberg R: Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281-2287, 1993
14. 2-induced acute renal failure: The effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA. J Am Soc Nephrol 5:1782-1791, 1995
15. 15. Martin AA, Gillespie CM, Moore L, Ballard FJ, Read LC: Effects of insulin-like growth factor-I peptides in rats with acute renal failure. J Endocrinol 140:23-32, 1994
16. 16. Noguchi S, Kashihara Y, Ikegami Y, Morimoto K, Miyamoto M, Nakao K: Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats. J Pharmacol Exp Ther 267:919-926, 1993
17. 17. Petrinec D, Reilly JM, Sicard GA, Lowell JA, Howard TK, Martin DR, Brennan DC, Miller SB: Insulin-like growth factor-I attenuates delayed graft function in a canine renal autotransplantation model. Surgery 120:221-225, 1996
18. 18. Hirschberg R, Ding H: Mechanisms of insulin-like growth factor-I-induced accelerated recovery in experimental ischemic acute renal failure. Miner Electrolyte Metab 24:211-219, 1998
19. 19. Metropolitan Life Insurance Company: 1983 Metropolitan height and weight tables. Stat Bull Metrop Insur Co 64:3, 1983
20. 20. Wagner DP, Draper EA: Acute physiology and chronic health evaluation (APACHE II) and Medicare reimbursement. Health Care Finance Rev (Suppl):91-105, 1984
21. 21. Parker RA, Himmelfarb J, Tolkoff-Rubin N, Chandran P, Wingard RL, Hakim RM: Prognosis of patients with acute renal failure requiring dialysis: Results of a multicenler study. Am J Kidney Dis 32:432-443, 1998
22. 22. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL: Serum somatomedin levels in adults with chronic renal failure: The importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab 63:1186-1192, 1986
23. 23. Engvall E, Perlmann P: Enzyme-linked immunosorbent assay, ELISA. 3. Quantification of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 109:129-135, 1972
24. 24. Blum WF, Horn N, Kratzsch J, Jorgensen JO, Juul A, Teale D, Mohnike K, Ranke MB: Clinical studies of IGFBP-2 by radio-immunoassay. Growth Regul 3:100-104, 1993
25. 25. Heinze E, Boker M, Blum W, Behnisch W, Schulz A, Urban J, Mauch E: IGF-I, IGFBP-3 and IGFBP-2 in cerebrospinal fluid of infants, during puberty and in adults. Exp Clin Endocrinol Diabetes 106:197-202, 1998
26. 26. Myers B, Nelson R, Williams G, Bennett P, Hardy S, Berg R, Loon N, Knowler W, Mitch W: Glomerular function in Pima Indians with non-insulin dependent diabetes mellitus of recent onset. J Clin Invest 88:524-534, 1991
27. 27. Miller SB, Hansen VA, Hammerman MR: Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. Am J Physiol 259:F747-F751, 1990
28. 28. Guler HP, Zapf J, Scheiwiller E, Froesch ER: Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85:4889-4893, 1988
29. 29. Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD: Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure: Evidence for a postreceptor defect. J Clin Invest 97:1064-1075, 1996
30. 30. Fouque D, Peng SC, Kopple JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 47:876-883, 1995
31. 31. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 43:1160-1178, 1993
32. 32. Hirschberg R, Kopple JD: Response of insulin-like growth factor I and renal hemodynamics to a high-and low-protein diet in the rat. J Am Soc Nephrol 1:1034-1040, 1991
33. 33. Feld SM, Hirschberg R, Artishevsky A, Nast C, Adler SG: Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int 48:45-51, 1995
34. 34. Ding H, Hirschberg R: Mechanisms of IGF-I-induced accelerated tubular recovery in ischemic acute renal failure. Miner Electrolyte Metab 24:211-219, 1998
35. 35. Fouque D, Peng SC, Kopple JD: Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int 47:869-875, 1995
36. 36. Feld S, Hirschberg R: Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev 17:423-480, 1996
37. 37. Miller SB, Moulton M, O'Shea M, Hammerman MR: Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 46:201-207, 1994
38. 38. Franklin C, Moulton M, Sicard G, Hammerman M, Miller S: Insulin-like growth factor I preserves renal function postoperatively. Am J Physiol 272:F257-F259, 1997